Protagonist Therapeutics (PTGX) Interest Coverage Ratio (2015 - 2025)
Protagonist Therapeutics (PTGX) reported Interest Coverage Ratio of 0.1 for Q4 2025, down 100.07% on a YoY basis from 150.75 in Q4 2024, and down 100.07% sequentially from 150.75 in Q4 2024.
Protagonist Therapeutics (PTGX) Interest Coverage Ratio (2015 - 2025) Analysis & Trends
Protagonist Therapeutics (PTGX) has 11 years of Interest Coverage Ratio data on file, last reported at 0.1 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio fell 100.07% year-over-year to 0.1; the trailing twelve-month figure through Dec 2025 stood at 0.32 (down 100.07% YoY), and the FY2025 full-year result was 0.32, down 119.08% from the prior year.
- Interest Coverage Ratio fell to 0.1 in Q4 2025, from 150.75 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 296.42 in Q1 2024 to a low of 66.58 in Q4 2021.
- A 5-year average of 10.3 and a median of 1.23 in 2021 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio slumped 13564.51% in 2022 and surged 52190.3% in 2024, its largest moves.
- Tracing PTGX's Interest Coverage Ratio over 5 years: stood at 66.58 in 2021, then increased by 18.74% to 54.1 in 2022, then jumped by 74.13% to 13.99 in 2023, then soared by 1177.2% to 150.75 in 2024, then tumbled by 100.07% to 0.1 in 2025.
- Business Quant data shows PTGX's Interest Coverage Ratio at 0.1 in Q4 2025, 150.75 in Q4 2024, and 21.6 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.10 |
| Dec 31, 2024 | 150.75 |
| Sep 30, 2024 | -21.60 |
| Jun 30, 2024 | -18.73 |
| Mar 31, 2024 | 296.42 |
| Dec 31, 2023 | -13.99 |
| Sep 30, 2023 | -55.30 |
| Jun 30, 2023 | -0.46 |
| Mar 31, 2023 | -0.57 |
| Dec 31, 2022 | -54.10 |
| Sep 30, 2022 | -14.04 |
| Jun 30, 2022 | -24.38 |
| Mar 31, 2022 | -0.46 |
| Dec 31, 2021 | -66.58 |
| Sep 30, 2021 | -1.23 |
| Jun 30, 2021 | -0.18 |
| Mar 31, 2021 | -0.36 |
| Dec 31, 2020 | 22.10 |
| Sep 30, 2020 | -0.20 |
| Jun 30, 2020 | -0.56 |